Skip to main content

Diagnostic options Β· UAE

Genetics tests in Dubai & UAE

Compare available Genetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

2,789

Listed price range

-1.00–50,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetics test prices

Showing 406–420 of 2,789 matching tests.

Genetics diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-3597
CDC73 Gene Familial Parathyroid Adenoma with Cystic Changes Genetic Test

This test evaluates the CDC73 gene for germline mutations associated with familial parathyroid adenoma with cystic changes, hyperparathyroidism-jaw tumor syndrome, and parathyroid...

Peripheral whole blood or FTA card (DNA) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["CDC73 gene mutations", "Germline variants"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of any medications"]
Indications
["Suspected familial parathyroid adenoma with cystic changes", "Suspected hyperparathyroidism-jaw tumor syndrome", "Suspected parathyroid carcinoma", "Family history of CDC73-related disorders"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: E21.0, D44.2, Z14.8
Clinical summary
This test evaluates the CDC73 gene for germline mutations associated with familial parathyroid adenoma with cystic changes, hyperparathyroidism-jaw tumor syndrome, and parathyroid carcinoma.
TEST-3745
CDC73 Gene Hyperparathyroidism Type 1, Familial Genetic Test

This genetic test identifies mutations in the CDC73 gene associated with Familial Hyperparathyroidism Type 1.

Peripheral Whole Blood 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["CDC73 gene mutations", "Copy number variants in CDC73"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of any relevant family history"]
Indications
["Suspected Familial Hyperparathyroidism Type 1", "Family history of CDC73-related disorders", "Assessment of cancer risk in parathyroid, jaw, and kidneys"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 92937-7 ICD-10: E21.0
Clinical summary
This genetic test identifies mutations in the CDC73 gene associated with Familial Hyperparathyroidism Type 1.
TEST-2085
CDH1 Hereditary Diffuse Gastric Cancer (HDGC) Genetic Test

This genetic test analyzes the CDH1 gene for pathogenic variants associated with Hereditary Diffuse Gastric Cancer (HDGC). It identifies mutations that increase the risk of develop...

Whole blood (EDTA), buccal swab, or FTA card 21–28 calendar days 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic germline variants in the CDH1 gene", "Copy Number Variants (CNVs) within the CDH1 gene"]
Parameters
[]
Preparation
["No fasting or dietary preparation required"]
Indications
["Two or more cases of diffuse gastric cancer in first- or second-degree relatives", "One case of diffuse gastric cancer before age 40", "Personal or family history of diffuse gastric cancer and lobular breast cancer (one diagnosis before age 50)", "Known CDH1 mutation in a blood relative"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: Z15.09
Clinical summary
This genetic test analyzes the CDH1 gene for pathogenic variants associated with Hereditary Diffuse Gastric Cancer (HDGC). It identifies mutations that increase the risk of developing diffuse gastric cancer and lobular breast cancer.
TEST-4833
CDH15 Gene Mental Retardation, Autosomal Dominant Type 3 (MRD3) Genetic Test

This genetic test evaluates the CDH15 gene for pathogenic variants associated with autosomal dominant intellectual disability type 3 (MRD3). It utilizes Next-Generation Sequencing...

Peripheral Whole Blood (preferred) or DNA on FTA Card 3 – 4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the CDH15 gene", "Coding region and splice-site boundaries of CDH15"]
Parameters
[]
Preparation
[]
Indications
["Children and adults presenting with unexplained intellectual disability", "Global developmental delay", "Family history consistent with autosomal dominant inheritance"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 104200-5 ICD-10: F78, Q99.8
Clinical summary
This genetic test evaluates the CDH15 gene for pathogenic variants associated with autosomal dominant intellectual disability type 3 (MRD3). It utilizes Next-Generation Sequencing (NGS) with Sanger validation for high accuracy.
TEST-5721
CDH23 Gene Deafness, Autosomal Recessive Type 12 (DFNB12) Genetic Test

This genetic test analyzes the CDH23 gene to identify pathogenic variants associated with autosomal recessive non-syndromic hearing loss type 12 (DFNB12).

Peripheral Whole Blood (EDTA Tube) or FTA Card Spot 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["CDH23 gene sequence", "Pathogenic variants in coding exons, splice junctions, and deep intronic regions"]
Parameters
[]
Preparation
["No fasting required.", "Stay well-hydrated."]
Indications
["Diagnosis of suspected DFNB12", "Carrier screening for CDH23 variants", "Premarital counselling", "Family planning"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81247-9 ICD-10: H90.3
Clinical summary
This genetic test analyzes the CDH23 gene to identify pathogenic variants associated with autosomal recessive non-syndromic hearing loss type 12 (DFNB12).
TEST-5224
CDH3 Gene Ectodermal Dysplasia, Ectrodactyly, and Macular Dystrophy Genetic Test

This genetic test analyzes the CDH3 gene to detect mutations associated with Ectodermal Dysplasia, Ectrodactyly, and Macular Dystrophy (EEM) syndrome.

Peripheral Whole Blood (EDTA) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["CDH3 gene coding regions", "CDH3 gene splice sites", "Copy number variants (CNVs) in CDH3"]
Parameters
[]
Preparation
["No fasting required", "Avoid strenuous exercise 24 hours before collection"]
Indications
["Suspected EEM syndrome based on clinical presentation", "Family history of EEM syndrome", "Need for definitive molecular diagnosis for genetic counseling"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21665-2 ICD-10: Q82.4, Q71.6, H35.38
Clinical summary
This genetic test analyzes the CDH3 gene to detect mutations associated with Ectodermal Dysplasia, Ectrodactyly, and Macular Dystrophy (EEM) syndrome.
TEST-3591
CDHR1 Gene Cone-Rod Dystrophy Type 15 Genetic Test

This test identifies pathogenic variants in the CDHR1 gene, confirming the diagnosis of autosomal recessive cone-rod dystrophy type 15.

Peripheral Whole Blood 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the CDHR1 gene"]
Parameters
[]
Preparation
["No specific fasting required", "Do not discontinue prescribed medication"]
Indications
["Clinical suspicion of cone-rod dystrophy type 15", "Family history of inherited retinal disorders"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94835-9 ICD-10: H35.52
Clinical summary
This test identifies pathogenic variants in the CDHR1 gene, confirming the diagnosis of autosomal recessive cone-rod dystrophy type 15.
TEST-2011
CDK4 Gene Melanoma (Familial Cutaneous Malignant) Genetic Test

This genetic test evaluates for inherited mutations in the CDK4 gene, which are associated with an increased risk of familial cutaneous malignant melanoma.

Peripheral Whole Blood 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["CDK4 gene mutations", "Inherited genetic predisposition to melanoma"]
Parameters
[]
Preparation
["Pre-test genetic counselling is mandatory", "Signed informed consent is required"]
Indications
["Individuals with a personal or family history suggestive of familial cutaneous malignant melanoma", "Risk assessment for melanoma"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-7 ICD-10: Z15.09
Clinical summary
This genetic test evaluates for inherited mutations in the CDK4 gene, which are associated with an increased risk of familial cutaneous malignant melanoma.
TEST-2562
CDK5RAP2 Gene Microcephaly, Autosomal Recessive Type 3 Genetic Test

This test detects pathogenic variants in the CDK5RAP2 gene associated with autosomal recessive primary microcephaly type 3 (MCPH3).

Peripheral Blood or Buccal Swab 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the CDK5RAP2 gene"]
Parameters
[]
Preparation
["Pre-test genetic counseling session is mandatory"]
Indications
["Suspected autosomal recessive primary microcephaly type 3 (MCPH3)", "Family history of MCPH3"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94222-8 ICD-10: Q02
Clinical summary
This test detects pathogenic variants in the CDK5RAP2 gene associated with autosomal recessive primary microcephaly type 3 (MCPH3).
TEST-2567
CDK6 Gene Microcephaly, Autosomal Recessive Type 12 Genetic Test

This test identifies pathogenic mutations in the CDK6 gene associated with autosomal recessive primary microcephaly type 12.

Peripheral Whole Blood (EDTA), Extracted DNA, or FTA Card Dried Blood Spot 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic mutations in the CDK6 gene", "Full gene coverage"]
Parameters
[]
Preparation
["No fasting required unless combined with other bloodwork", "Bring prior medical records, neuroimaging reports, and family history documentation"]
Indications
["Clinical suspicion of autosomal recessive primary microcephaly type 12", "Family history of CDK6-related disorders", "Carrier screening", "Prenatal diagnosis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-5 ICD-10: Q02
Clinical summary
This test identifies pathogenic mutations in the CDK6 gene associated with autosomal recessive primary microcephaly type 12.
TEST-3837
CDKL5 Deficiency Disorder (Angelman‑like Syndrome) Genetic Test

This test identifies genetic variants in the CDKL5 gene associated with early-onset epileptic encephalopathy resembling Angelman syndrome.

Whole Blood (peripheral) / Dried Blood Spot on FTA Card 3–4 weeks from sample receipt 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the CDKL5 gene", "Single nucleotide variants (SNVs)", "Small insertions/deletions (indels)", "Copy number variants (CNVs)"]
Parameters
[]
Preparation
["No specific fasting required", "Patients must continue all prescribed anti-epileptic medications"]
Indications
["Suspected CDKL5 deficiency disorder", "Early-onset epileptic encephalopathy", "Clinical features resembling Angelman syndrome"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94121-4 ICD-10: G40.42
Clinical summary
This test identifies genetic variants in the CDKL5 gene associated with early-onset epileptic encephalopathy resembling Angelman syndrome.
TEST-1981
CDKN1B Gene Multiple Endocrine Neoplasia Type 4 (MEN4) Genetic Test

This test evaluates the CDKN1B gene for germline mutations associated with Multiple Endocrine Neoplasia Type 4 (MEN4). It identifies hereditary predisposition to developing multipl...

Peripheral whole blood (4ml) or finger-prick dried blood spot (FTA card) 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["CDKN1B gene mutations", "Point mutations", "Small insertions/deletions", "Copy number variations"]
Parameters
[]
Preparation
["Fasting is not necessary", "Pre-test genetic counselling session is mandatory", "Provide family cancer history"]
Indications
["Individuals with a personal or family history suggestive of MEN4", "Assessment of hereditary risk for multiple endocrine tumors"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 104160-3 ICD-10: E31.29
Clinical summary
This test evaluates the CDKN1B gene for germline mutations associated with Multiple Endocrine Neoplasia Type 4 (MEN4). It identifies hereditary predisposition to developing multiple endocrine tumors.
TEST-2708
CDKN1C Gene IMAGE Syndrome Genetic Test

This test analyzes the entire coding region of the CDKN1C gene using NGS to identify pathogenic variants associated with IMAGE syndrome.

Whole blood (EDTA), FTA card blood spot, or extracted genomic DNA 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["CDKN1C gene variants", "Pathogenic mutations"]
Parameters
[]
Preparation
[]
Indications
["Suspected IMAGE syndrome", "Pediatric dysmorphology work-up", "Neonatal growth restriction", "Family history of IMAGE syndrome"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 93360-0 ICD-10: Q87.8
Clinical summary
This test analyzes the entire coding region of the CDKN1C gene using NGS to identify pathogenic variants associated with IMAGE syndrome.
TEST-1999
CDKN2A Gene Melanoma, Cutaneous Malignant, Familial Genetic Test

This test evaluates the CDKN2A gene for inherited mutations associated with an increased risk of familial melanoma.

Peripheral whole blood (EDTA) or dried blood spot (FTA card) 3 – 4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["CDKN2A gene mutations", "Point mutations", "Small indels", "Copy number variants (deletions/duplications)"]
Parameters
[]
Preparation
["No fasting required", "No specific medication or diet restrictions"]
Indications
["Individuals with a family history of melanoma", "Individuals with multiple atypical moles", "Assessment of risk for FAMMM syndrome"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21658-0 ICD-10: Z15.01
Clinical summary
This test evaluates the CDKN2A gene for inherited mutations associated with an increased risk of familial melanoma.
TEST-2750
CDON Gene Holoprosencephaly Type 11 (HPE11) Genetic Test

This genetic test evaluates the CDON gene for pathogenic variants associated with Holoprosencephaly type 11 (HPE11).

Whole Blood (EDTA), Dried Blood Spot (FTA Card), or Extracted DNA 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["CDON gene pathogenic variants"]
Parameters
[]
Preparation
["No specific fasting required", "Inform phlebotomist of anticoagulants or bleeding diathesis"]
Indications
["Suspected Holoprosencephaly type 11", "Family history of HPE11", "Prenatal screening findings suggestive of HPE11"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94800-0 ICD-10: Q04.2
Clinical summary
This genetic test evaluates the CDON gene for pathogenic variants associated with Holoprosencephaly type 11 (HPE11).

Category overview

Genetics: overview

Understanding your unique biological blueprint offers a profound sense of clarity and empowers proactive health planning for you and your family. At DNA Labs UAE, our specialized Genetics division employs state-of-the-art molecular technologies to provide deep insights into hereditary markers and cellular mutations. This comprehensive genetics testing in the UAE equips your healthcare provider with the precise data needed to tailor your medical guidance effectively. Recognized among top diagnostic labs in Dubai and the UAE, we prioritize your peace of mind through strict confidentiality protocols and exceptionally fast, accurate reporting. Take the next step in your health journey. View our genetics diagnostic services, book a private home collection, or consult our specialized team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area